Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone for POAF Prophylaxis in High-Risk Lung and Esophageal Surgery Patients
NCT04392921Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Mar 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Atrial fibrillation (AFib) comparing Amiodarone Arm with Placebo Arm (2 arms). Primary endpoints: Capability for enrolment at 1 year, Proportion of patients randomized who receive the intervention at 1 year and 6 more. Status: unknown.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04392921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04392921.